Digestives & Intestinal Remedies - India

In 2024, the Digestives & Intestinal Remedies market market in India is projected to generate a revenue of US$774.80m.
It is anticipated that the market will experience an annual growth rate of 6.45% (CAGR 2024-2029).
Comparing globally, China leads the market with a revenue of US$4.41bn in 2024.
When considering the total population, the per person revenue in India is estimated to be US$0.54 in 2024.
India's growing population and increasing awareness of digestive health have led to a surge in demand for digestive and intestinal remedies in the OTC pharmaceutical market.

Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestives & Intestinal Remedies market in India has been experiencing significant growth in recent years.

Customer preferences: Indian consumers are increasingly becoming health-conscious and are seeking natural remedies for digestive issues. This has led to a growing demand for digestive and intestinal remedies that are made from natural ingredients and have minimal side effects. Customers are also looking for products that are easily accessible and affordable.

Trends in the market: One major trend in the Digestives & Intestinal Remedies market in India is the increasing popularity of herbal and Ayurvedic remedies. Ayurveda, an ancient Indian system of medicine, has gained recognition for its ability to address digestive issues. This has led to the introduction of a wide range of Ayurvedic digestive and intestinal remedies in the market. Additionally, there is a growing trend of consumers opting for probiotic supplements to improve their gut health.

Local special circumstances: India has a rich tradition of using natural remedies for various ailments, including digestive issues. The country is known for its diverse range of herbs and spices that are used in traditional medicine. This cultural preference for natural remedies has contributed to the growth of the Digestives & Intestinal Remedies market in India. Additionally, the country's large population and increasing disposable income have created a favorable market for digestive and intestinal remedies.

Underlying macroeconomic factors: India's rapidly growing middle class and rising disposable income levels have played a significant role in the growth of the Digestives & Intestinal Remedies market. As more people have the financial means to prioritize their health and well-being, the demand for digestive and intestinal remedies has increased. Furthermore, the government's initiatives to promote traditional medicine and Ayurveda have also contributed to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in India is experiencing growth due to the increasing health-consciousness among consumers, the popularity of herbal and Ayurvedic remedies, the cultural preference for natural remedies, and the country's favorable macroeconomic factors.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.